We are live on ! Find out more
EDIT icon

Editas Medicine

206 hedge funds and large institutions have $64.8M invested in Editas Medicine in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 57

2% more call options, than puts

Call options by funds: $396K | Put options by funds: $388K

5.01% less ownership

Funds ownership: 66.86%61.84% (-5%)

10% less funds holding

Funds holding: 229206 (-23)

33% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 58

65% less capital invested

Capital invested by funds: $188M → $64.8M (-$123M)

Holders
206
Holders Change
-23
Holders Change %
-10.04%
% of All Funds
2.71%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
61
Reduced
57
Closed
58
Calls
$396K
Puts
$388K
Net Calls
+$8K
Net Calls Change
-$354K
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
126
Osaic Holdings
Arizona
$7.66K -$3.92K -1,539 -20%
California State Teachers Retirement System (CalSTRS)
127
California State Teachers Retirement System (CalSTRS)
California
$7.63K -$174K -68,101 -92%
New York State Common Retirement Fund
128
New York State Common Retirement Fund
New York
$5.58K
AWM
129
Activest Wealth Management
Florida
$5.08K
WWP
130
WR Wealth Planners
Missouri
$4.03K
AB
131
Amalgamated Bank
New York
$4K
National Bank of Canada
132
National Bank of Canada
Quebec, Canada
$3.79K +$2.11K +828 +38%
SS
133
SBI Securities
Japan
$3.58K +$7.17K +2,816 New
SCM
134
Sterling Capital Management
North Carolina
$3.58K +$6.38K +2,502 +799%
RS
135
R Squared
Hong Kong
$3.48K +$6.98K +2,740 New
SAM
136
Synergy Asset Management
Washington
$3.41K +$2.55K +1,000 New
Mirae Asset Global Investments
137
Mirae Asset Global Investments
South Korea
$3.33K -$591 -232 -8%
Nisa Investment Advisors
138
Nisa Investment Advisors
Missouri
$2.55K +$1.21K +474 +31%
EPIM
139
Evelyn Partners Investment Management
$2.48K +$4.97K +1,950 New
GFM
140
GF Fund Management
China
$2.32K +$4.66K +1,830 New
WIM
141
Westside Investment Management
California
$1.97K
Jones Financial Companies
142
Jones Financial Companies
Missouri
$1.91K +$275 +108 +8%
S
143
SignatureFD
Georgia
$1.83K -$20.1K -7,886 -85%
NA
144
NewEdge Advisors
Louisiana
$1.65K -$535 -210 -14%
TLCM
145
Twin Lakes Capital Management
California
$1.59K
Comerica Bank
146
Comerica Bank
Texas
$1.44K +$2.46K +966 +589%
WSFS
147
Wilmington Savings Fund Society
Delaware
$1.27K
KPP
148
Kings Path Partners
Texas
$1.27K +$2.55K +1,000 New
LSA
149
Leonteq Securities AG
Switzerland
$963
EWA
150
EverSource Wealth Advisors
Alabama
$685 +$1.37K +539 New

EDIT Hedge Fund Activity: Q4 2024 in Review

206 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2024, worth a combined $64.8M — down 65% from $188M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of EDIT and 39 opened new positions — a net loss of 19 holders — while 57 trimmed existing stakes and 61 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $3.7M. The largest seller was Deep Track Capital, exiting entirely with an estimated $16.7M sold.

  • 206 institutional investors held Editas Medicine (EDIT) as of Q4 2024, down from 229 in Q3 2024.
  • Funds reported $64.8M of Editas Medicine stock for Q4 2024, down 65% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2024 and 58 closed out, a net change of -19 holders.
  • The largest Editas Medicine buyer in Q4 2024 was Renaissance Technologies, an estimated $3.7M added.
  • The largest Editas Medicine seller in Q4 2024 was Deep Track Capital, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2024.